“An experimental drug combination cured 70 percent of patients with hepatitis C in early trials, offering hope of a simpler remedy for the chronic liver disease, US researchers said Tuesday. The phase II trial described in the Journal of the American Medical Association (JAMA) studied the effectiveness and safety of an experimental drug, sofosbuvir, taken with the licensed antiviral drug ribavirin.  The drugs were administered orally, an improvement over the current treatment which involves weekly injections with interferon-alpha and can cause depression, flu-like symptoms and anemia.  All nine who completed the regimen had no virus detectable 24 weeks after therapy ended.”

http://www.rawstory.com/rs/2013/08/27/experimental-drug-cures-70-percent-of-patients-with-hepatitis-c/

Did you like this?
Tip Freedomwat.ch Staff with Bitcoin

Donate via Installed Wallet Copy